Key result
Non-vitamin K antagonist oral anticoagulants (NOACs) nomenclature is addressed in response to arguments that these agents are no longer new or novel.
Key points are not available for this paper at this time.
Retains NOAC terminology for clinical use; leaves nomenclature evolution open pending broader consensus.
Note: The review process for this paper was fully handled by Christian Weber, Editor in Chief.
No takes yet. Share an insight, caveat, or question.
Lip et al. (2014) studied this question. Non-vitamin K antagonist oral anticoagulants (NOACs) nomenclature is addressed in response to arguments that these agents are no longer new or novel.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: